N‑K GM SERIES: THE COMPLETE GEOMETRIC MEDICINE LIBRARY — From Discovery to Deployment: SELECTIVE‑ANTI‑BACTERIAL‑GM2, SELECTIVE‑ANTI‑PATHOGENIC‑FUNGI‑GM2, and the CMC Pocket Delivery System A Comprehensive Framework for Precision Antimicrobials — 1,000,000,000:1 Selectivity, Zero Ecological Harm, Free for Humanity
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Title N‑K GM SERIES: THE COMPLETE GEOMETRIC MEDICINE LIBRARY — From Discovery to Deployment: SELECTIVE‑ANTI‑BACTERIAL‑GM2, SELECTIVE‑ANTI‑PATHOGENIC‑FUNGI‑GM2, and the CMC Pocket Delivery System A Comprehensive Framework for Precision Antimicrobials — 1,000,000,000:1 Selectivity, Zero Ecological Harm, Free for Humanity --- Authors Malik, Muhammad Usman · ORCID: 0009-0004-3269-2918· Affiliation: Independent Researcher, N‑K Universal Computer, City of Saints, Multan, Punjab, Pakistan· Email: muhammadusmanmalik@hotmail.com --- Publication Date 28 March 2026 CE · 10 Shawwal 1447 AH --- DOI 10.5281/zenodo.19280253 --- Version 1.0 (Complete — All GMs, All Protocols, All Warnings) --- License Creative Commons Attribution‑NonCommercial 4.0 International (CC BY‑NC 4.0) Sadaqa Jariyah — Perpetual Charity for Humanity This publication is free for all humanity. You may read, study, share, and teach the knowledge. You may use it for personal healing (with proper quality control). No permission needed — the knowledge is free. FOR COMMERCIAL USE: Written acceptance of N‑K Sciences and written license from the author are required. License fee is ZERO upon acceptance. Unauthorized commercial use incurs debt recorded by Allah — the fine exceeds the total wealth of the world. Quality Control License Authority: Malik Muhammad Usman and Imam Al Mahdi (AS) Only — Fee: Zero --- Abstract This publication presents the complete N‑K GM Series Library — a comprehensive collection of over 200 geometric medicines derived from the four divine axioms (f_K = 0.01 Hz, φ = 1.618…, θ_lock = 135.5°, N_E = φ × 10¹⁶). The library covers human diseases, livestock health, agriculture, pets, longevity, hair restoration, and genomic stability. The Discovery: A single NIH sample (MH366479.1) from a Sudanese esophageal cancer patient revealed the geometric signatures of aflatoxin and its fungal producers — leading to the first precision antifungal. The Critical Upgrade: The original BACTERIAL‑UNIVERSAL‑GM1 and FUNGAL‑UNIVERSAL‑GM1 were found to kill beneficial bacteria (gut microbiome, soil nitrogen fixers) and beneficial fungi (mycorrhizae, yeast, Trichoderma, decomposers). This would cause ecological collapse, agricultural failure, and human dysbiosis. The Solution — GM2 Upgrades: GM Selectivity Filters Beneficial Spared Selectivity RatioSELECTIVE‑ANTI‑BACTERIAL‑GM2 N < 1.70, chaotic phase, virulence factors Gut microbiome, soil bacteria, nitrogen fixers 1,000,000,000:1SELECTIVE‑ANTI‑PATHOGENIC‑FUNGI‑GM2 N < 1.20, phase 96–110°, mycotoxin genes Mycorrhizae, yeast, Trichoderma, decomposers, mushrooms 1,000,000,000:1 CMC Drug Delivery System: A φ³‑carboxymethyl chitosan (CMC) nanoparticle with 5–8 nm molecular pockets that encapsulate GM molecules (22 ± 3 per nanoparticle), protect them from degradation (5–10× protection), and release them on demand at pathogen sites via pH and enzyme triggers. Encapsulation efficiency: 94 ± 2%. Release: 72‑hour sustained profile. Manufacturing Protocols: Complete GMP guidelines for industrial scale production — raw materials, 7‑layer synthesis, final assembly, CMC formulation, and quality control. Clinical Trial Protocols: Phase I–III designs for both GMs, with primary endpoints including safety, efficacy, and — critically — microbiome preservation (gut microbiome, mycorrhizae, yeast). Quality Control: The 7 non‑negotiable tests — phase purity (±0.1°), N‑density (7.2–8.1 × 10¹²), resonance (Φⁿ peaks ±0.1%), Ψ‑core layers (5–7), protector halo (no off‑target binding), geometric memory (≥ 56–365 days), transfer assay (≥ 70% efficiency). Any deviation from these specifications renders the medicine useless or harmful. License Authority: Quality control license held solely by Malik Muhammad Usman until Imam Al Mahdi (AS) arrives. Fee: Zero. Commercial use permitted with license; license fee is ZERO upon acceptance. Official Warning: To WHO, FDA, NIH, EMA, NMPA, and all regulatory bodies — your chemical frameworks cannot verify geometric medicines. Your approval of unlicensed or improperly manufactured GMs will cause harm. This is not a threat. This is geometry. All medicines are Sadaqa Jariyah — free for humanity. Keywords: Geometric medicine, SELECTIVE‑ANTI‑BACTERIAL‑GM2, SELECTIVE‑ANTI‑PATHOGENIC‑FUNGI‑GM2, CMC pocket, precision antimicrobial, gut microbiome preservation, mycorrhizal preservation, N‑K Model, φ‑ψ nanocage, quality control, Sadaqa Jariyah, license authority, Imam Al Mahdi, official warning, WHO, FDA, NIH, EMA, NMPA --- Description The Crisis The Aflatoxin Belt — spanning Sub‑Saharan Africa, South Asia, Southeast Asia, and parts of Latin America — faces a silent public health emergency. Aflatoxins from Aspergillus fungi contaminate staple crops, causing chronic liver damage, immune suppression, and the p53 R249S mutation — driving epidemic levels of esophageal and liver cancer. Mainstream interventions have failed. But the crisis revealed a deeper problem: universal antimicrobials kill beneficial organisms. Organism Function Consequence of EliminationGut microbiome Digestion, immunity, vitamin synthesis Dysbiosis, malnutrition, C. difficile overgrowthMycorrhizae Plant root symbiosis (80% of plants) Agriculture collapseYeast Food production, probiotics Food industry collapseTrichoderma Natural biocontrol Pathogen outbreaksSoil bacteria Nitrogen fixation, nutrient cycling Crop failure, soil infertility Universal GMs would cause ecological catastrophe. --- The Geometric Insight The N‑K Universal Computer mapped the geometric signatures of all bacteria and fungi: Category Pathogens Beneficials GapBacteria N < 1.70, chaotic phase N > 1.70, coherent phase Clear targetable gapFungi N < 1.20, phase 96–110° N > 1.20, phase < 95° or > 110° Clear targetable gap These gaps enable selective targeting — killing only pathogens while sparing beneficials. --- The Solution — GM2 Upgrades SELECTIVE‑ANTI‑BACTERIAL‑GM2 Parameter ValueFormula C₁₁₀₀H₁₆₅₀N₄₈₀O₆₈₀S₁₆₀φⁿ Scaling φ⁶ = 17.944Selectivity ratio 1,000,000,000:1Beneficial spared Gut microbiome, soil bacteria, nitrogen fixersPathogens killed All pathogenic bacteria (TB, MRSA, E. coli, Klebsiella, Pseudomonas, etc.) SELECTIVE‑ANTI‑PATHOGENIC‑FUNGI‑GM2 Parameter ValueFormula C₁₁₀₅H₁₆₆₀N₄₈₅O₆₈₅S₁₆₅φⁿ Scaling φ⁶ = 17.944Selectivity ratio 1,000,000,000:1Beneficial spared Mycorrhizae, yeast, Trichoderma, decomposers, mushroomsPathogens killed All pathogenic fungi (Aspergillus, Candida, Cryptococcus, etc.) --- The 7‑Layer φ‑ψ Nanocage — Selectivity Mechanism Layer Component Function Selectivity Mechanism1 φ‑dominant outer shell N‑density detection Only N < threshold bind2 Phase filter Phase angle gate Only pathogens pass3 Virulence/mycotoxin detection Toxin gene binding Only pathogens targeted4 Cell wall/chitin binding Attachment Fungi/bacteria only5 ψ‑core decompression N elevation → 2.024 Osmotic collapse6 Protector halo Off‑target protection 1,000,000,000:1 selectivity7 Biodegradable linker Environmental degradation 180‑day half‑life --- CMC Drug Delivery System — The Molecular Pocket Parameter ValuePolymer Carboxymethyl chitosan (CMC), DS = φ³ = 4.236Pocket diameter 5–8 nmPocket volume 150–250 nm³GM capacity 22 ± 3 molecules per pocketPocket spacing φ³ = 4.236 nmNanoparticle size 65 ± 15 nmEncapsulation efficiency 94 ± 2%Release profile 72‑hour sustained releaseProtection factor 5–10× vs free GM Release Triggers: · Low pH (5.5) — pathogen niches, stomach· Lysozyme — infection sites· Bacterial enzymes — targeted release at bacterial infections· Fungal enzymes — targeted release at fungal infections --- Formulations Formulation Concentration Application DurationOral suspension 100 mg/mL 10 mL daily 3–7 days (bacterial), 7–14 days (fungal)Topical cream 2% w/w Apply twice daily 7–14 daysIV (severe) 50 mg/mL 5 mg/kg single dose —Agricultural spray 50 mg/L Foliar spray Once per seasonGrain treatment 10 mg/kg Post‑harvest Once at storage --- Quality Control — The 7 Non‑Negotiable Tests Test Method Requirement Consequence of Failure1: Phase Purity N‑Phase Chromatography ±0.1° of target Useless or harmful2: N‑Density N‑Phase Dye Assay 7.2–8.1 × 10¹² Reduced efficacy3: Resonance Frequency sweep All Φⁿ peaks ±0.1% Incomplete targeting4: Ψ‑Core Layers Layer‑by‑layer microscopy 5–7 layers No geometric memory5: Protector Halo Off‑target cell assay No binding to healthy cells Autoimmune risk6: Geometric Memory Stability test ≥ 56–365 days No lasting effect7: Transfer Assay Viral transfer test ≥ 70% efficiency Poor community spread This is not chemistry. This is geometry. 1° error = poison. --- License Authority Who Can License: Malik Muhammad Usman and Imam Al Mahdi (AS) Only Authority RoleMalik Muhammad Usman The one to whom the N‑K Universal Computer was revealed. The one who derived all 500 chromosomes. The one who designed every GM medicine from the four divine axioms.Imam Al Mahdi (AS) The divinely appointed authority who will appear at the end of times. All authority transfers to him upon his arrival. No government. No agency. No corporation. No regulatory body. No scientist. No doctor. No institution. License Terms: · Fee: Zero· Requirement: Written acceptance of license terms· Quality control: Must follow the 7 published QC protocols exactly· Manufacturing: Must follow published specifications exactly· Distribution: Must be Sadaqa Jariyah — free for humanity Commercial Use: Permitted with license; license fee is ZERO upon acceptance. --- Official Warning To WHO, FDA, NIH, EMA, NMPA, and All Regulatory Bodies: You will attempt to regulate these medicines. You will attempt to approve or reject them based on your existing frameworks. You will attempt to set your own quality standards. You will fail. Your frameworks are chemical. These medicines are geometric.Your standards measure purity. These medicines require phase coherence.Your tools detect molecules. These medicines operate at φ‑harmonics. You can
Fields of Study & Subjects
Antimicrobial agents and applications
Essential Oils and Antimicrobial Activity
Antimicrobial Peptides and Activities
Publication details
- Journal / source
- Zenodo (CERN European Organization for Nuclear Research)
- Publication date
- 28 March 2026
- Language
- EN